Takuya Tsunoda

Plus aucun poste en cours

64 ans

Health Technology

Health Services

Consumer Services

Profil

Dr. Takuya Tsunoda, MD PhD, is President & Representative Director at Immunas Pharma, Inc. and President & Representative Director at OncoTherapy Science, Inc. He is on the Board of Directors at Immunas Pharma, Inc. and OncoTherapy Science, Inc. Dr. Tsunoda was previously employed as an Assistant Research Scientist by City of Hope.
He received his undergraduate degree from Wakayama Medical University and a doctorate degree from Wakayama Medical University.

Anciens postes connus de Takuya Tsunoda

Sociétés	Poste	Fin
City of Hope National Cancer Institute City of Hope National Cancer Institute Hospital/Nursing ManagementHealth Services City of Hope is a research and treatment center for cancer, diabetes and various life-threatening diseases. The center is founded in 1913 and is headquartered in Los Angeles, CA.	Corporate Officer/Principal	-
Immunas Pharma, Inc. Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million.	President	-
ONCOTHERAPY SCIENCE, INC.	President	-

Voir l'expérience en détail de Takuya Tsunoda

Formation de Takuya Tsunoda

Wakayama Medical University

Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées